These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15635020)

  • 1. Activities of available and investigational antifungal agents against rhodotorula species.
    Diekema DJ; Petroelje B; Messer SA; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2005 Jan; 43(1):476-8. PubMed ID: 15635020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
    Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
    Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.
    Zaas AK; Boyce M; Schell W; Lodge BA; Miller JL; Perfect JR
    J Clin Microbiol; 2003 Nov; 41(11):5233-5. PubMed ID: 14605170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.
    Pfaller MA; Messer SA; Boyken L; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Jul; 42(7):3142-6. PubMed ID: 15243073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.
    Nunes JM; Bizerra FC; Ferreira RC; Colombo AL
    Antimicrob Agents Chemother; 2013 Jan; 57(1):382-9. PubMed ID: 23114761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
    Preney L; Théraud M; Guiguen C; Gangneux JP
    Mycoses; 2003 Dec; 46(11-12):492-5. PubMed ID: 14641623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of the isolation of Candida species from hospitalized patients.
    Magalhães YC; Bomfim MR; Melônio LC; Ribeiro PC; Cosme LM; Rhoden CR; Marques SG
    Braz J Microbiol; 2015 Mar; 46(1):117-23. PubMed ID: 26221096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN; Diekema DJ
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1723-7. PubMed ID: 12019081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.
    Pfaller MA; Messer SA; Georgopapadakou N; Martell LA; Besterman JM; Diekema DJ
    J Clin Microbiol; 2009 Dec; 47(12):3797-804. PubMed ID: 19794038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.
    Galán-Sánchez F; García-Martos P; Rodríguez-Ramos C; Marín-Casanova P; Mira-Gutiérrez J
    Mycopathologia; 1999; 145(3):109-12. PubMed ID: 10685444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzon A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):917-21. PubMed ID: 16495251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.
    Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
    J Antimicrob Chemother; 2005 Mar; 55(3):312-6. PubMed ID: 15695538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
    Falces-Romero I; Cendejas-Bueno E; Romero-Gómez MP; García-Rodríguez J
    Mycoses; 2018 Jan; 61(1):35-39. PubMed ID: 28922488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal activity of posaconazole and caspofungin in yeast causing invasive fungal infection (2002-2003). E-test system evaluation].
    Fernández A; Velasco D; Lueiro F; Bou G
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):82-4. PubMed ID: 18341919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    Thompson GR; Wiederhold NP; Sutton DA; Fothergill A; Patterson TF
    J Antimicrob Chemother; 2009 Jul; 64(1):79-83. PubMed ID: 19406849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species identification, antifungal susceptibility profiles and biofilm formation attributes of Rhodotorula isolates from ocular infections.
    Ahmed NH; Xess I; Singh G; Satpathy G; Sharma N; Agarwal T; Hussain T; Chawla R; Tandon R
    Mycoses; 2021 Oct; 64(10):1183-1196. PubMed ID: 34228832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility of 64 strains of Rhodotorula sp.
    Krzyściak P; Macura AB
    Wiad Parazytol; 2010; 56(2):167-70. PubMed ID: 20707302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.